Cargando…
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by (18)F-FDG PET/CT: A case report
RATIONALE: The case reported the rapid remission of disease recurrence achieved adding foscarnet, a DNA polymerase inhibitor that interacts with fibroblast growth factor 2, to low molecular weight heparin and sunitinib for the first time in a patient with an anaplastic thyroid cancer (ATC). PATIENT...
Autores principales: | Giannetta, Elisa, Isidori, Andrea M., Durante, Cosimo, Di Gioia, Cira, Longo, Flavia, Tombolini, Vincenzo, Bulzonetti, Nadia, Graziadio, Chiara, Pofi, Riccardo, Gianfrilli, Daniele, Verrienti, Antonella, Carletti, Raffaella, Filetti, Sebastiano, Lenzi, Andrea, Baroli, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312981/ https://www.ncbi.nlm.nih.gov/pubmed/28178124 http://dx.doi.org/10.1097/MD.0000000000005621 |
Ejemplares similares
-
Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter: Two Case Reports
por: Giannetta, Elisa, et al.
Publicado: (2016) -
Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid
por: Pecce, Valeria, et al.
Publicado: (2020) -
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency
por: Pecce, Valeria, et al.
Publicado: (2018) -
Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials
por: Giannetta, Elisa, et al.
Publicado: (2014) -
OR21-6 Diabetic Cardiac Hypertrophy Is Associated With Viscoelastic Changes In Myocardial Contraction: Role Of Hsa-mir-122-5p On Extracellular Matrix.
por: Isidori, Andrea, et al.
Publicado: (2019)